GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Modern Diagnostic & Research Centre Ltd

Modern Diagnostic and Research Centre Monitors IPO Fund Utilization

FUNDRAISE ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 17 Nov 2026, 11:27 AM IST  ·  BSE ID: 2f31e66b-b93d-4337-ba01-42eff9b2401c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's IPO money is being used as planned for new equipment, according to an independent check.
🤖 AI Summary
  • Monitoring agency confirms Rs. 36.89 crore IPO funds used per offer document.
  • Funds allocated to capital expenditure for diagnostic equipment and labs.
  • Report covers quarter ended September 30, 2026, for IPO monitoring.
  • No material deviations or change in means of finance observed.
🔢 Key Numbers - exact figures from BSE filing, not rounded
IPO Issue Size
Rs.36.89 crore
Quarter Ended
September 30, 2026
🏢 How This Affects the Company
📈
Business Impact
Confirms adherence to IPO objectives, reinforcing business plans for diagnostic center expansion.
💰
Financial Impact
Provides assurance on the responsible deployment of Rs. 36.89 crore raised through the IPO.
⚙️
Operational Impact
Ongoing utilization for capital expenditure indicates continued investment in operational capacity.
⚠️
Risk Impact
Reduces risk perception related to IPO fund mismanagement. Notes a delay in one objective's utilization.
👥 What This Means For Shareholders
✅
Action Required
No action required by shareholders regarding this monitoring report.
👤
Who Is Affected
All shareholders are affected by the assurance of proper IPO fund utilization, impacting long-term company value.
🔍
Management Signal
Management is demonstrating compliance with regulatory requirements and IPO commitments.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next monitoring agency report for Q3 FY27 funds utilization.
Company filings detailing actual deployment of capital expenditure.
Operational updates on new diagnostic equipment and laboratory setup.
LOW RISK Report confirms adherence to IPO fund utilization plan, reducing financial risk.
💡 Investor Takeaway
Modern Diagnostic and Research Centre's Rs. 36.89 crore IPO funds are being utilized as disclosed, primarily for diagnostic equipment, with no material deviations reported.
⚖️ Strengths & Concerns

✅ Positives

  • IPO proceeds of Rs. 36.89 crore are being utilized as per offer document disclosures.
  • No material deviations observed in fund utilization or change in means of finance.

⚠️ Concerns

  • A delay exists in the utilization of IPO proceeds for capital expenditure, attributed to factors beyond control.
📅 Company Track Record
This is the first monitoring agency report available for Modern Diagnostic and Research Centre Limited following its Initial Public Offer.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the total value of Modern Diagnostic and Research Centre Limited's Initial Public Offer (IPO)?
The total issue size of the Initial Public Offer for Modern Diagnostic and Research Centre Limited was Rs.36.89 crore.
How are the IPO proceeds of Modern Diagnostic and Research Centre Limited being utilized?
The IPO proceeds are being utilized for funding capital expenditure for the purchase of medical equipment for diagnostic centres and laboratories.
Has Modern Diagnostic and Research Centre Limited deviated from its IPO offer document disclosures?
No, the monitoring agency report indicates that the utilization of funds is as per the offer document, with no material deviations observed.
What is the period covered by the latest monitoring agency report for Modern Diagnostic and Research Centre Limited?
The monitoring agency report covers the quarter ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.

Live IPO, GMP and market updates on Telegram

IPO open and close dates, grey market premium moves, subscription figures, allotment and listing days, and the market updates worth knowing about, posted on the channel as they happen.

Join the channel